DZ Bank’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History

DZ Bank’s Portfolio ARLZ Stock Details ARLZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-283,235	Closed	-$425K	–	1212
2018 Q1	$425K	Buy	+283,235	New	+$494K	﹤0.01%	818

Other funds holding ARLZ

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Salzhauer Michael $292M AUM 30% 1-Year Est. Return

PCM

PAR Capital Management Boston, Massachusetts $3.45B AUM 28.5% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

SCP

Silverleafe Capital Partners Germantown, Tennessee $367M AUM 37.49% 1-Year Est. Return

FSA

Franklin Street Advisors Chapel Hill, North Carolina $1.79B AUM 28.1% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

DZ Bank's ARLZ Position: Q2 2018 in Review

DZ Bank sold out of Aralez Pharmaceuticals Inc. (ARLZ) in Q2 2018, closing a stake of 283,235 shares — an estimated $425K sold.

DZ Bank first reported a position in ARLZ in Q1 2018 and held it in 1 quarter. The position peaked at $425K in Q1 2018. 48 funds tracked by Wall St. Rank hold ARLZ as of Q2 2018.

DZ Bank reported no remaining Aralez Pharmaceuticals Inc. position as of Q2 2018 after selling out during the quarter.
DZ Bank sold 283,235 Aralez Pharmaceuticals Inc. shares in Q2 2018, an estimated $425K.
DZ Bank first reported a position in Aralez Pharmaceuticals Inc. in Q1 2018 and held it in 1 quarter.
DZ Bank's Aralez Pharmaceuticals Inc. position peaked at $425K in Q1 2018.
48 funds tracked by Wall St. Rank held Aralez Pharmaceuticals Inc. as of Q2 2018.

Based on DZ Bank's 13F filing for Q2 2018, filed 14 Aug 2018.